US Stock MarketDetailed Quotes
BNGO Bionano Genomics
- 0.6176
- -0.0166-2.62%
Close Jul 24 16:00 ET
- 0.6300
- +0.0124+2.01%
Post 19:47 ET
49.91MMarket Cap-99P/E (TTM)
0.6700High0.6020Low1.64MVolume0.6300Open0.6342Pre Close1.04MTurnover2.27%Turnover RatioLossP/E (Static)80.81MShares6.189052wk High0.60P/B44.64MFloat Cap0.520052wk Low--Dividend TTM72.28MShs Float156.9000Historical High--Div YieldTTM10.72%Amplitude0.5200Historical Low0.6320Avg Price1Lot Size
Bionano Genomics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 18.26%8.77M | 29.90%36.12M | 30.51%10.72M | 29.04%9.32M | 29.87%8.66M | 30.18%7.42M | 54.62%27.8M | 30.36%8.22M | 55.12%7.22M | 72.98%6.67M |
| Operating revenue | 18.26%8.77M | 29.90%36.12M | 30.51%10.72M | 29.04%9.32M | 29.87%8.66M | 30.18%7.42M | 54.62%27.8M | 30.36%8.22M | 55.12%7.22M | 72.98%6.67M |
| Cost of revenue | 11.23%5.95M | 21.47%26.55M | 29.22%8.28M | 21.38%6.57M | 22.22%6.35M | 10.55%5.35M | 54.94%21.86M | 5.72%6.41M | 54.58%5.41M | 115.10%5.2M |
| Gross profit | 36.43%2.82M | 60.91%9.57M | 35.07%2.44M | 51.96%2.75M | 56.90%2.31M | 140.42%2.07M | 53.46%5.95M | 655.23%1.81M | 56.76%1.81M | 2.22%1.47M |
| Operating expense | -26.55%29.32M | 7.18%147.53M | -30.36%27.39M | 13.91%38.68M | 23.83%41.55M | 29.57%39.91M | 69.98%137.64M | 35.52%39.33M | 55.54%33.96M | 87.27%33.55M |
| Selling and administrative expenses | -24.79%19.54M | 5.53%93.5M | -38.04%15.69M | 17.35%24.9M | 23.66%26.94M | 28.11%25.98M | 51.47%88.6M | 27.84%25.32M | 38.42%21.22M | 57.52%21.78M |
| Research and development costs | -29.83%9.78M | 10.16%54.03M | -16.49%11.7M | 8.19%13.79M | 24.16%14.61M | 32.39%13.94M | 118.13%49.05M | 52.05%14.01M | 95.88%12.74M | 187.98%11.77M |
| Operating profit | 30.00%-26.49M | -4.76%-137.97M | 33.51%-24.95M | -11.77%-35.93M | -22.32%-39.24M | -26.38%-37.84M | -70.81%-131.7M | -30.38%-37.53M | -55.47%-32.15M | -94.70%-32.08M |
| Net non-operating interest income expense | 46.82%922K | -249.55%-1.81M | -633.67%-3.71M | 81.54%659K | 421.19%615K | 1,803.03%628K | 274.96%1.21M | 2,216.67%695K | 1,244.44%363K | 156.19%118K |
| Non-operating interest income | 48.30%1.04M | 119.71%3.31M | 54.42%1.19M | 67.43%730K | 258.85%689K | 540.00%704K | 538.56%1.51M | 816.67%770K | 1,403.45%436K | 231.03%192K |
| Non-operating interest expense | 60.53%122K | 1,617.79%5.12M | 6,430.67%4.9M | -2.74%71K | 0.00%74K | -1.30%76K | -67.85%298K | 38.89%75K | 3,550.00%73K | -72.39%74K |
| Other net income (expense) | -5,117.95%-5.87M | -41,450.67%-92.66M | -38,062.50%-15.27M | -1,545,180.00%-77.25M | -64.10%-256K | 454.55%117K | 38.06%-223K | -208.11%-40K | 107.46%5K | 92.54%-156K |
| Special income (charges) | ---4.63M | ---77.28M | --0 | ---77.28M | ---- | --0 | --0 | --0 | --0 | ---- |
| -Less：Restructuring and merger&acquisition | --4.63M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| -Less:Impairment of capital assets | ---- | --77.28M | --0 | --77.28M | ---- | ---- | --0 | --0 | --0 | ---- |
| Other non- operating income (expenses) | -1,158.97%-1.24M | -6,795.96%-15.38M | -38,062.50%-15.27M | 420.00%26K | -64.10%-256K | 454.55%117K | -277.97%-223K | -208.11%-40K | 107.46%5K | -940.00%-156K |
| Income before tax | 15.25%-31.44M | -77.82%-232.43M | -19.13%-43.93M | -254.07%-112.53M | -21.05%-38.88M | -23.90%-37.1M | -67.25%-130.71M | -28.40%-36.87M | -53.40%-31.78M | -71.04%-32.12M |
| Income tax | -169.23%-18K | -96.71%62K | -101.99%-36K | 39.29%39K | -19.51%33K | 188.89%26K | 132.95%1.88M | 131.30%1.81M | -20.00%28K | 355.56%41K |
| Net income | 15.36%-31.42M | -75.34%-232.49M | -13.48%-43.89M | -253.88%-112.57M | -21.00%-38.91M | -23.94%-37.12M | -83.06%-132.6M | -68.53%-38.68M | -53.27%-31.81M | -71.18%-32.16M |
| Net income continuous Operations | 15.36%-31.42M | -75.34%-232.49M | -13.48%-43.89M | -253.88%-112.57M | -21.00%-38.91M | -23.94%-37.12M | -83.06%-132.6M | -68.53%-38.68M | -53.27%-31.81M | -71.18%-32.16M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 15.36%-31.42M | -75.34%-232.49M | -13.48%-43.89M | -253.88%-112.57M | -21.00%-38.91M | -23.94%-37.12M | -83.06%-132.6M | -68.53%-38.68M | -53.27%-31.81M | -71.18%-32.16M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 15.36%-31.42M | -75.34%-232.49M | -13.48%-43.89M | -253.88%-112.57M | -21.00%-38.91M | -23.94%-37.12M | -83.06%-132.6M | -68.53%-38.68M | -53.27%-31.81M | -71.18%-32.16M |
| Basic earnings per share | 51.22%-0.6 | -48.69%-6.81 | 26.24%-0.96 | -192.73%-3.22 | -9.73%-12.4 | -11.82%-1.23 | -76.15%-4.58 | -64.24%-1.3015 | -57.14%-1.1 | -1,514.29%-11.3 |
| Diluted earnings per share | 51.22%-0.6 | -48.69%-6.81 | 26.24%-0.96 | -192.73%-3.22 | -9.73%-12.4 | -11.82%-1.23 | -76.15%-4.58 | -64.24%-1.3015 | -57.14%-1.1 | -1,514.29%-11.3 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg